NDC 68084-206-11
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68084-206
- Requested NDC
- 68084-206-11
- Package NDCs from labels
- 68084-206-11
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2012-07-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68084-206-01 | EA - Each | 68084-206 | 7af864de-7d5e-44e6-8ee3-70cffbc37209 | 1 | 2012-07-24 |
| 68084-206-11 | EA - Each | 68084-206 | daa4e993-7b09-4293-af17-eea3f43b8e5a | 1 | 2012-07-24 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Spironolactone | SPIRONOLACTONE | Preferred Pharmaceuticals Inc. | 5e456f3c-f93e-41c6-80c5-a737ed70feda | 2026-08-31 | Warnings, Adverse reactions | ANDA040750 |
| Spironolactone | SPIRONOLACTONE | Preferred Pharmaceuticals Inc. | 4290b3ec-8993-47d4-bfe3-fcb81d7baed8 | 2026-08-31 | Warnings, Adverse reactions | ANDA040750 |
| Spironolactone | SPIRONOLACTONE | REMEDYREPACK INC. | 7646ca22-710e-4a5c-9613-b829e2f9d5ce | 2026-08-17 | Warnings, Adverse reactions | ANDA040750 |
| Spironolactone | SPIRONOLACTONE | REMEDYREPACK INC. | b119ed8a-289a-46c5-9778-6b07e4c061c4 | 2026-08-14 | Warnings, Adverse reactions | ANDA040750 |
| Spironolactone | SPIRONOLACTONE | PD-Rx Pharmaceuticals, Inc. | 73564b3d-8ede-4008-b75c-1277153b5bb6 | 2026-07-17 | Warnings, Adverse reactions | ANDA040750 |
| Spironolactone | SPIRONOLACTONE | PD-Rx Pharmaceuticals, Inc. | 8a66d90e-5450-4716-8c01-e7dc1967d00d | 2026-07-17 | Warnings, Adverse reactions | ANDA040750 |
| Spironolactone | SPIRONOLACTONE | PD-Rx Pharmaceuticals, Inc. | 8cbe2215-744c-438a-b3d6-b7d6ae769231 | 2026-07-17 | Warnings, Adverse reactions | ANDA040750 |
| Spironolactone | SPIRONOLACTONE | REMEDYREPACK INC. | 8f0291a9-c8a6-4298-a540-23abc01fae09 | 2026-07-09 | Warnings, Adverse reactions | ANDA040750 |
| Spironolactone | SPIRONOLACTONE | Coupler LLC | 56050192-c499-64bd-e063-6294a90acbeb | 2026-07-07 | Warnings, Adverse reactions | ANDA040750 |
| Spironolactone | SPIRONOLACTONE | Coupler LLC | 53454970-2c0f-54c3-e063-6294a90aac0a | 2026-06-02 | Warnings, Adverse reactions | ANDA040750 |
| Spironolactone | SPIRONOLACTONE | Proficient Rx LP | 6782c1c1-d1ac-4c07-b7cb-a74699d2f9fe | 2026-05-01 | Warnings, Adverse reactions | ANDA040750 |
| Spironolactone | SPIRONOLACTONE | Proficient Rx LP | 6867776e-b4fd-41db-8da8-a5af76eed280 | 2026-04-01 | Warnings, Adverse reactions | ANDA040750 |
| Spironolactone | SPIRONOLACTONE | Direct_Rx | ffd2f3f5-c7c8-0028-e053-6394a90aaf17 | 2026-03-05 | Warnings, Adverse reactions | ANDA040750 |
| Spironolactone | SPIRONOLACTONE | NuCare Pharmaceuticals,Inc. | 4b9a20c4-46f2-d572-e063-6294a90a30ad | 2026-02-25 | Warnings, Adverse reactions | ANDA040750 |
| Spironolactone | SPIRONOLACTONE | NuCare Pharmaceuticals, Inc. | 4b4af7e0-f35b-9bf6-e063-6294a90a83b9 | 2026-02-20 | Warnings, Adverse reactions | ANDA040750 |
| Spironolactone | SPIRONOLACTONE | Oxford Pharmaceuticals, LLC | 852684dc-e1c6-4caa-bccb-10ac90bbb3bb | 2026-02-17 | Warnings, Adverse reactions | ANDA040750 |
| Spironolactone | SPIRONOLACTONE | Coupler LLC | 472ee2ad-7e57-bef1-e063-6394a90a0206 | 2025-12-30 | Warnings, Adverse reactions | ANDA040750 |
| Spironolactone | SPIRONOLACTONE | A-S Medication Solutions | bb29ea6f-c294-4895-9e9b-544d69651a35 | 2025-12-03 | Warnings, Adverse reactions | ANDA040750 |
| Spironolactone | SPIRONOLACTONE | A-S Medication Solutions | c328f555-2da8-43ac-bc04-0e89d4d2aa53 | 2025-12-02 | Warnings, Adverse reactions | ANDA040750 |
| Spironolactone | SPIRONOLACTONE | A-S Medication Solutions | cd64e343-e15e-43b1-88b5-a3d5ba23fedf | 2025-11-26 | Warnings, Adverse reactions | ANDA040750 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.